Patients on beta blockers showed a trend toward a reduction in major adverse events (HR 0.86 [0.74–1.01]), while the effect of DAT was neutral (HR 0.90 [0.74–1.08]) [ 52 ].
← all excerpts
The PROMISE of Precision Medicine in Myocardial Infarction with Non-Obstructive Coronary Arteries.
1
—
—